Preliminary program outline
The preliminary program outline is now available.
Conference program
The AFPS 2025 Conference offers a dynamic three-day program designed to maximise learning and networking opportunities.
Each day will begin with thought-provoking keynote presentations from leaders in pharmaceutical science, followed by concurrent sessions of oral presentations, panel discussions and debate, workshops, and innovation showcases. The program will feature expert-led panel discussions on critical topics including digital therapeutics, bio convergence and sustainable pharmaceutical practices.
Interactive workshops and masterclasses will provide hands-on experience with cutting-edge laboratory techniques and professional development training.
Program highlight
Thanks to our Knowledge Partner and Session Sponsor: Craft Health.
Shaping the new tomorrow of pharmaceutical formulations with 3D printing: Join interactive sessions and live demos on 3D printed pharmaceuticals.
Throughout the conference, dedicated poster sessions will showcase emerging research, while the innovation hub will host live demonstrations of breakthrough technologies. Networking sessions are strategically scheduled to facilitate meaningful connections among attendees.
A detailed program schedule, including confirmed speakers and session times, will be released in mid-2025 with the content focused on the following themes:
Conference themes
- Advances in genomics, gene editing, and precision medicine.
- Ethical/legal considerations and regulatory challenges.
- Nuclear science in pharmaceutical and medical sciences
- Advancements in in vitro models, organoids, and computational simulations.
- 3Rs and cruelty-free research and development.
- Nanotechnology applications in drug formulation and targeted delivery.
- Extracellular vesicles as drug delivery vectors and adjuvants.
- Safety, efficacy, and scalability.
- Next-generation antimicrobials.
- Alternative therapies such as bacteriophage-based treatments, CRISPR-Cas antimicrobials, and microbiome-derived agents
- One health approaches to AMR
- Regulatory policies and stewardship programs.
- Innovations in 3D printing for the pharmaceutical industry.
- Regulatory considerations in 3D printed pharmaceuticals.
- Clinical applications and case studies of 3D printed drugs.
- AI for drug discovery, patient care, and supply chain optimization.
- Ethical implications and data privacy.
- Autonomous labs for sample processing, quality control, and inventory management.
- Safety protocols and cost-effectiveness.
- Collaboration between pharmaceutical companies and research institutions.
- Success stories and best practices.
- Hospital drug management, patient safety, and clinical pharmacy.
- Interdisciplinary teamwork.
- Medicine without Meds – transforming Patient Care with Digital Therapies
- Inaugural forum for an Asian Paediatric Formulation Initiative
- Development and evaluation of age-appropriate paediatric formulations
- Taste-masking strategies for paediatric formulations
- Evidence-based herbal medicine, traditional practices, and holistic approaches – indigenous medicines.
- Synergies with pharmaceuticals.
- Mechanopharmacology in drug discovery.
- Mechanobiology as a biomarker in drug development and testing.